Envista Holdings Corp
NYSE:NVSTMedical - Equipment & Services
+$0.76 today
- Market cap
- $3.81B
- Beta
- 0.89
- P/E (TTM)
- 62.0
- EPS (TTM)
- $0.41
Volume 1.92M
Average 2.94M
NVST EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Envista Holdings CorpNYSE: NVST
EBITDA · Q3 FY2026 · quarter ended Oct 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $515.2M rose 484.8% year over year, ahead of the +154.2% change in trailing-twelve-month EBITDA. Sequentially, it rose 267.7% from the prior quarter. Over 3 fiscal years it compounded at -14.2% a year.
Context
- EBITDA amounted to 12.1% of revenue in FY2025, up 1.0 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 11 analysts of $473.83M (+43.7%) for the fiscal year ending Dec 2026, a step up from the +18.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterOct 2026
- $515.2M+267.7% QoQ
- Last fiscal yearDec 2025
- $329.8M+18.0% YoY
- LTMOct 2026
- $835.4M+154.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +484.8% | +41.5% | -443.3 pp |
| 1 year | +18.0% | +43.7% | +25.7 pp |
| 3-year CAGR | -14.2% | +14.2% | +28.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 329.8M USD
- Year-over-year change
- +18.0%
- 4-year CAGR
- -10.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 329.8M | +18.0% |
| FY2024 | 2024-12-31 | 279.5M | -43.0% |
| FY2023 | 2023-12-31 | 490M | -6.1% |
| FY2022 | 2022-12-31 | 522M | -0.4% |
| FY2021 | 2021-12-31 | 524.3M | — |
EBITDA vs competitors
How NVST compares with its peers on the latest reported figures
- NVST's LTM Oct 2026 EBITDA of $835.4M is the highest of the 11 companies compared; the peer median is -$71.43M.
- Its year-over-year change of +154.2% is the 2nd highest of 11, against a peer median of -0.5%.
- EBITDA amounts to 29.0% of revenue for NVST, versus a peer median of 7.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $835.4M | +154.2% | -14.2% | 29.0% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $478.53M | +19.3% | +7.4% | 20.5% |
| LTM Jun 2026 | $247.61M | -23.3% | +17.3% | 11.5% | |
| LTM Jun 2026 | $68.17M | +79.4% | — | 2.9% | |
| LTM Mar 2026 | $66.42M | +265.7% | — | 1.6% | |
| LTM Jun 2026 | -$15.87M | -109.6% | -34.8% | 1.9% | |
| LTM Mar 2026 | -$127M | +74.8% | — | 3.5% | |
| LTM Jun 2026 | -$291.3M | -23.0% | — | — | |
| LTM Jun 2026 | -$374.1M | +10.8% | — | 226.4% | |
| LTM Jun 2026 | -$495.35M | -20.6% | — | — | |
| LTM Mar 2026 | -$503.35M | -11.9% | — | 75.2% | |
| Peer median (excluding NVST) | -$71.43M | -0.5% | +7.4% | 7.5% | |
Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.51B | 2.57B | 2.57B | 2.51B | 2.72B |
| Cost of Revenue | 1.05B | 1.08B | 1.12B | 1.12B | 1.22B |
| Gross Profit | 1.46B | 1.49B | 1.45B | 1.39B | 1.5B |
| Gross Margin | 58.3% | 57.9% | 56.5% | 55.4% | 55.0% |
| Research & Development | 100.5M | 100.1M | 93.8M | 99.1M | 114M |
| Selling, General & Admin | 989.5M | 1.03B | 1.03B | 1.14B | 1.16B |
| Operating Expenses | 1.16B | 1.17B | 1.42B | 2.43B | 1.27B |
| Depreciation & Amortization | 151.9M | 162.1M | 162.6M | 123.1M | 116M |
| EBITDA | 524.3M | 522M | 490M | 279.5M | 329.8M |
| EBITDA Margin | 20.9% | 20.3% | 19.1% | 11.1% | 12.1% |
| Operating Income | 306.2M | 319.2M | 31.5M | (1.04B) | 225.7M |
| Operating Margin | 12.2% | 12.4% | 1.2% | -41.4% | 8.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 54.1M | 38.4M | 63.4M | 46.4M | 36.6M |
| Other Income / Expenses | (51.7M) | (35.3M) | (86.4M) | (46.5M) | (48.5M) |
| Income Before Tax | 254.5M | 283.9M | (54.9M) | (1.08B) | 177.2M |
| Pre-Tax Margin | 10.1% | 11.1% | -2.1% | -43.2% | 6.5% |
| Income Tax Expense | (9M) | 45.9M | 45.3M | 33.9M | 130.2M |
| Net Income | 340.5M | 243.1M | (100.2M) | (1.12B) | 47M |
| Net Margin | 13.6% | 9.5% | -3.9% | -44.6% | 1.7% |
| EPS (Basic) | 1.63 | 1.46 | (0.60) | (6.50) | 0.28 |
| EPS (Diluted) | 1.48 | 1.34 | (0.60) | (6.50) | 0.28 |
| Weighted Avg Shares | 161.2M | 162.9M | 166.9M | 172.2M | 168M |
| Weighted Avg Shares (Diluted) | 177.6M | 177.6M | 166.9M | 172.2M | 169.2M |
Envista Holdings Corp
NYSE:NVST
Intrinsic Alpha fair value
Locked
Current Price
$23.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.